menu
    • menu

    Company profile for Neurogene

    NEW Drugs in Dev: 3
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies. Although the human genome was sequenced for the first time nearly 20 year...
    Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies. Although the human genome was sequenced for the first time nearly 20 years ago, the true genomics revolution is taking place now, providing us with the ability to radically alter rare, genetic disorders. At Neurogene,

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeurogeneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    535 W 24th Street, 5th Floor New York, NY 10011
    Telephone
    Telephone
    1-877-237-5020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurogene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurogene/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neurogene Completes Dosing in NGN-401 Rett Syndrome Trial
    Neurogene Completes Dosing in NGN-401 Rett Syndrome Trial

    08 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260608913151/en/Neurogene-Announces-Successful-Completion-of-Dosing-in-Embolden-Registrational-Trial-of-NGN-401-for-Rett-Syndrome

    BUSINESSWIRE
    08 Jun 2026
    Share Share
    Neurogene Announces Inducement Grants Under Nasdaq Rules
    Neurogene Announces Inducement Grants Under Nasdaq Rules

    02 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260602697652/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    02 Jun 2026
    Share Share
    Neurogene Reports Q1 2026 Results and Recent Updates
    Neurogene Reports Q1 2026 Results and Recent Updates

    12 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260512420099/en/Neurogene-Reports-First-Quarter-2026-Financial-Results-and-Highlights-Recent-Updates

    BUSINESSWIRE
    12 May 2026
    Share Share
    Neurogene Presents ICV Gene Therapy Delivery Data at ASGCT
    Neurogene Presents ICV Gene Therapy Delivery Data at ASGCT

    12 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260512663376/en/Neurogene-Highlights-Data-at-ASGCT-Meeting-Supporting-Therapeutic-Rationale-for-ICV-Delivery-Method-in-CNS-targeted-Gene-Therapy

    BUSINESSWIRE
    12 May 2026
    Share Share
    Neurogene Reports Inducement Grants Under Nasdaq Rule
    Neurogene Reports Inducement Grants Under Nasdaq Rule

    06 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-06/neurogene-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4

    PHARMIWEB
    06 May 2026
    Share Share
    Neurogene Reports Inducement Grants Under Nasdaq Listing Rule
    Neurogene Reports Inducement Grants Under Nasdaq Listing Rule

    06 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260506621244/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    06 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search